source
- Lilly's oral GLP-1 pill Foundayo reduces sleep apnea events in late-stage trialsIn two late-stage trials, Eli Lilly’s oral GLP‑1 pill Foundayo lowered the apnea‑hypopnea index by an average of 17.8 events per hour, compared with a 4.5‑event reduction for patients on placebo.…
- Democrats weigh limits of health-care reforms after midterm winIn the days after their sweeping midterm victories, House and Senate Democrats are debating the scope of possible health-care actions. Party leaders agree on rolling back the Medicaid cuts impleme…